This is a preview of subscription content, log in via an institution to check access.
References
Alliance Pharmaceutical Corp. announces commencement of Imagent (Rm) phase III clinical trials. PR Newswire [online]. [2 pages], 1 Apr 1998. Available from: URL: http://www.newspage.com
Walker KW, Sahn DJ, Grauer SE, et al. Studies of bubble persistence vs standard and harmonic mode acoustic pulse pressure for three new echocontrast agents. Journal of the American College of Cardiology. 29 (Suppl A): 300, Feb 1997
Cotter B, Ohmori K, Duong A, et al. Influence of ultrasonic energy on contrast echocardiography: intermittent imaging using AF0150 yields generalized myocardial opacification while continuous imaging delineates intramyocardial vessels. Journal of the American College of Cardiology. 29 (Suppl A): 300, Feb 1997
Cotter B, Mulvagh S, Kwan OL, et al. Safety and efficacy of AF0150 for cardiac contrast enhancement in normal subjects: initial results of a phase I clinical trial. Journal of the American College of Cardiology. 29 (Suppl A): 300, Feb 1997
Halpern EJ, Verkh L, Forsberg F, et al. Initial experience with contrast-enchanced sonography of the prostate. American Journal of Roentgenology. 174: 1575–1580, Jun 2000
Rights and permissions
About this article
Cite this article
AFO 150. Drugs R&D 3, 116–118 (2002). https://doi.org/10.2165/00126839-200203020-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-200203020-00011